News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith W Bradford
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Smith W Bradford (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 02/27/2023 |
4
| Smith W Bradford (See remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 213,000 options to buy
@ $1.6, valued at
$340.8k
Granted 36,000 restricted stock units
@ $0 |
|
| 01/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Smith W Bradford (CFO & Treasurer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 126,000 options to buy
@ $2.71, valued at
$341.5k
Granted 21,000 restricted stock units
@ $0 |
|
| 01/12/2022 |
4
| Smith W Bradford (CFO & Treasurer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 2,182 shares
@ $3.7802, valued at
$8.2k
Exercised 6,600 restricted stock units
@ $0 |
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
3
| Smith W Bradford (Director) has filed a Form 3 on Lyra Therapeutics, Inc. |
| 02/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 111,000 options to buy
@ $19.92, valued at
$2.2M
|
|
| 12/03/2019 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 6,000 shares
@ $16, valued at
$96k
Sold 6,000 shares
@ $16.211, valued at
$97.3k
Exercised 6,000 options to buy
@ $0.64, valued at
$3.8k
Exercised 6,000 options to buy
@ $0.64, valued at
$3.8k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2019 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 6,000 shares
@ $18.7365, valued at
$112.4k
Exercised 6,000 options to buy
@ $0.64, valued at
$3.8k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 6,000 shares
@ $18.9952, valued at
$114k
Exercised 6,000 options to buy
@ $0.64, valued at
$3.8k
|
|
| 06/05/2019 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 6,000 shares
@ $19.944, valued at
$119.7k
Exercised 6,000 options to buy
@ $0.64, valued at
$3.8k
|
|
| 12/18/2018 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 88,000 options to buy
@ $24.28, valued at
$2.1M
|
|
| 03/29/2018 |
4
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 49,711 options to buy
@ $16, valued at
$795.4k
|
|
| 03/27/2018 |
3
| Smith W Bradford (CFO, Treasurer & Secretary) has filed a Form 3 on Homology Medicines, Inc. |
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|